Administration of IMODs significantly reduced lipid peroxidation (a marker of oxidative stress) and increased superoxide dismutase, catalase and glutathione peroxidase (markers of antioxidant potential) levels in hyperandrogenism-induced PCOS. Here, CAT is linked to hyperandrogenism.